Long term continuous treatment with topical corticosteroids should be avoided as far as possible as this may cause atophic changes in the skin leading to thinning, loss of elasticity, dilatation of superficial blood vessels, telangiectasiae, ecchymoses, urticaria, contact dermatitis (ointment only) and rash. These changes are particularly likely to occur when occlusive dressings are used. Systemic absorption of topically applied corticosteroids may occur, particularly under the following conditions when large quantities are used or when application is made to wide areas of the body, or to damaged skin, when potent topical corticosteroids are used and when the occlusive dressing technique is applied. Depression of the hypothalamic-pituitary-adrenal axis with consequent suppression of the adrenal gland may occur. These effects are most likely to be severe in children. Growth may be retarded and a Cushingoid state may be produced. Benign intracranial hypertension has been rarely reported. None of these side effects have been reported following the use of Proctosedyl.
Before prescribing the product any potential malignancies should be excluded.
Visual disturbance may be reported with systemic and topical corticosteroid use. If a patient presents with symptoms such as blurred vision or other visual disturbances, the patient should be considered for referral to an ophthalmologist for evaluation of possible causes which may include cataract, glaucoma or rare diseases such as central serous chorioretinopathy (CSCR) which have been reported after use of systemic and topical corticosteroids.
The following special precaution is recommended: If a secondary microbial skin infection is present, suitable concomitant anti-microbial therapy should be instituted.
Suppository: In persons sensitive to any of the ingredients of the suppositories, anal irritation may occur.